Eighty-five percent of adults with atopic dermatitis also reported a sexual health disorder, but the frequency of these ...
Increasing maternal prepregnancy body mass index (ppBMI) and increasing birth length are associated with offspring atopic dermatitis.
Recommendations are presented for the prevention and management of pediatric atopic dermatitis in 2 recent guidelines.
Corvus Pharmaceuticals is developing an oral drug for a common skin condition that could push its shares a lot higher, ...
Most patients and doctors know that stress exacerbates AD. A new study pinpoints a neural mechanism that may be involved in ...
Already FDA-approved for adults and children 12 years or older, researchers explore extending the nemolizumab age range down to 2 years in atopic dermatitis.
Higher prepregnancy body mass index and longer birth length increase the risk for atopic dermatitis among offspring.
VTAMA was the only steroid-free topical AAD found supported by high certainty of evidence across all severities in children 2 years and older with AD.
Affecting up to 20% of all children, eczema is very common. But the condition—which causes itching and overall discomfort—can ...
After receiving dupilumab vs. topical corticosteroid or prednisone for up to 24 months, the risk for alopecia areata ...
The American Academy of Dermatology’s first pediatric atopic dermatitis guidelines note limited evidence for most preventive interventions, with early moisturizer use conditionally recommended ...
Amlitelimab is safe and effective, with potentially progressive efficacy over time, for patients with moderate-to-severe atopic dermatitis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results